Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trialFelix S. Lichtenegger, Marion Subklewe, Frauke M. Schnorfeil et al.|Clinical & Translational Immunology|2020Cited by 39
CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patientsSimone Weber, Dirk H. Busch, Ana-Marija Jetzlsperger et al.|PLoS ONE|2022Cited by 35